Pretreatment neutrophil-to-lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration-sensitive prostate cancer.
Cancer Rep (Hoboken)
; 4(5): e1392, 2021 10.
Article
in En
| MEDLINE
| ID: mdl-34159754
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphocytes
/
Biomarkers, Tumor
/
Prostatic Neoplasms, Castration-Resistant
/
Neutrophils
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Cancer Rep (Hoboken)
Year:
2021
Document type:
Article
Affiliation country:
Jordan
Country of publication:
United States